Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its oncology…
Read More

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its oncology…
Read More
A recent, highly focused one-day program convened leading experts to provide a deep dive into the evolving landscape of digital…
Read More
In a landmark presentation that underscored the transformative potential of advanced medical technology, Christina Baranetsky, Senior Administrative Director of Pathology…
Read More
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced its third significant…
Read More
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its strategic…
Read More
The integration of NVIDIA’s accelerated computing and BioNeMo platform with QIAGEN Digital Insights’ bioinformatics capabilities is poised to usher in…
Read More
In a strategic move to enhance precision in oncology drug development, Japanese pharmaceutical giant Daiichi Sankyo has announced a significant…
Read More
The formidable capacity of next-generation sequencing (NGS) technologies to simultaneously interrogate a vast spectrum of genetic mutations has firmly established…
Read More
The landscape of molecular diagnostics and life science research has been profoundly reshaped by the advent and maturation of digital…
Read More
The landscape of gene expression analysis is undergoing a significant transformation with the increasing adoption of Droplet Digital™ PCR (ddPCR™)…
Read More